Avaí Bio, Inc. (formerly Avant Technologies Inc.) reported its financial results for the three and nine months ended December 31, 2025, revealing a continued lack of revenue generation. The company recorded a net loss of $553,727 for the three months, compared to a loss of $452,298 in the same period the previous year, marking a 22% increase in losses. For the nine-month period, the net loss was $1,494,332, a decrease of 7% from the $1,606,187 loss reported for the same period in 2024. The total operating expenses for the three months increased by 19% to $509,774, driven primarily by higher laboratory and marketing expenses.
In terms of financial position, Avaí Bio's total assets decreased to $172,912 as of December 31, 2025, down from $224,745 at the end of the previous fiscal year. The company's liabilities rose significantly to $2,967,398, resulting in a stockholders' deficit of $2,794,486, up from $1,563,872 in March 2025. The company had cash reserves of $50,402, a decline from $81,053 reported earlier. The working capital deficit also widened to $2,906,546, indicating ongoing financial challenges.
Strategically, Avaí Bio has been active in expanding its technological capabilities through acquisitions. The company acquired assets from Avant! AI and Instant Fame in April 2023, enhancing its portfolio in artificial intelligence and digital technologies. Additionally, Avaí Bio entered into joint ventures with Ainnova Tech Inc. and SGAustria Pte. Ltd., focusing on healthcare technology and cell-based products, respectively. These initiatives are part of the company's broader strategy to leverage AI and technology for business transformation.
Despite these developments, the company faces significant operational challenges, including a lack of revenue and ongoing losses. Management has expressed concerns about its ability to continue as a going concern without additional capital. The company is exploring options for raising funds to support its operations and growth initiatives, but there is no assurance that it will be successful in securing the necessary financing. The outlook remains uncertain as Avaí Bio navigates its financial difficulties while attempting to capitalize on its technological investments.
About AVANT TECHNOLOGIES INC.
Avant Technologies Inc. specializes in developing and acquiring advanced artificial intelligence (AI) technologies and providing IT consulting services. Its core offerings include AI-driven software solutions featuring unsupervised and supervised learning models that enhance data analysis and reasoning. Serving businesses seeking innovative AI applications, Avant leverages proprietary technology and full-stack development capabilities to deliver scalable, data-efficient systems. The company operates primarily in technology and AI sectors, targeting enterprise clients through software and consulting services.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.